EGF Receptor in Tumor Growth and Progression:
Members of the tyrosine kinase family are frequently implicated in experimental as well as in human cancer. The best studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1997
|
| Schriftenreihe: | Ernst Schering Foundation Symposium Proceedings
19 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | Members of the tyrosine kinase family are frequently implicated in experimental as well as in human cancer. The best studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying molecular mechanisms for aberrant receptor signaling in experimental systems and present the status of current therapies directed against the receptor. A detailed analysis of EGF receptor signal transduction via expression of receptor, ligands, phosphatases and presence of other members of the receptor family will provide new information for the design of therapeutic modalities targeting this receptor system |
| Beschreibung: | 1 Online-Ressource (XVI, 258 p. 67 illus) |
| ISBN: | 9783662033913 |
| DOI: | 10.1007/978-3-662-03391-3 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046146462 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1997 |||| o||u| ||||||eng d | ||
| 020 | |a 9783662033913 |9 978-3-662-03391-3 | ||
| 024 | 7 | |a 10.1007/978-3-662-03391-3 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-662-03391-3 | ||
| 035 | |a (OCoLC)1119089123 | ||
| 035 | |a (DE-599)BVBBV046146462 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 |2 23 | |
| 084 | |a XH 1800 |0 (DE-625)152873:12905 |2 rvk | ||
| 084 | |a XH 1805 |0 (DE-625)152873:12911 |2 rvk | ||
| 245 | 1 | 0 | |a EGF Receptor in Tumor Growth and Progression |c edited by R. B. Lichtner, R. N. Harkins |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1997 | |
| 300 | |a 1 Online-Ressource (XVI, 258 p. 67 illus) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Ernst Schering Foundation Symposium Proceedings |v 19 | |
| 520 | |a Members of the tyrosine kinase family are frequently implicated in experimental as well as in human cancer. The best studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying molecular mechanisms for aberrant receptor signaling in experimental systems and present the status of current therapies directed against the receptor. A detailed analysis of EGF receptor signal transduction via expression of receptor, ligands, phosphatases and presence of other members of the receptor family will provide new information for the design of therapeutic modalities targeting this receptor system | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Pharmacy | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Pharmacy | |
| 650 | 0 | 7 | |a Tumorwachstum |0 (DE-588)4186432-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Epidermaler Wachstumsfaktor |0 (DE-588)4271160-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Epidermaler Wachstumsfaktor-Rezeptor |0 (DE-588)4271161-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1996 |z Berlin |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Epidermaler Wachstumsfaktor-Rezeptor |0 (DE-588)4271161-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Epidermaler Wachstumsfaktor |0 (DE-588)4271160-5 |D s |
| 689 | 1 | 1 | |a Tumorwachstum |0 (DE-588)4186432-3 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Lichtner, R. B. |4 edt | |
| 700 | 1 | |a Harkins, R. N. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783662033937 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540617204 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783662033920 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-662-03391-3 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031526647 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-662-03391-3 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180484480040960 |
|---|---|
| any_adam_object | |
| author2 | Lichtner, R. B. Harkins, R. N. |
| author2_role | edt edt |
| author2_variant | r b l rb rbl r n h rn rnh |
| author_facet | Lichtner, R. B. Harkins, R. N. |
| building | Verbundindex |
| bvnumber | BV046146462 |
| classification_rvk | XH 1800 XH 1805 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-662-03391-3 (OCoLC)1119089123 (DE-599)BVBBV046146462 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-662-03391-3 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03222nmm a2200649zcb4500</leader><controlfield tag="001">BV046146462</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1997 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783662033913</subfield><subfield code="9">978-3-662-03391-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-662-03391-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-662-03391-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119089123</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146462</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1800</subfield><subfield code="0">(DE-625)152873:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1805</subfield><subfield code="0">(DE-625)152873:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">EGF Receptor in Tumor Growth and Progression</subfield><subfield code="c">edited by R. B. Lichtner, R. N. Harkins</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVI, 258 p. 67 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Ernst Schering Foundation Symposium Proceedings</subfield><subfield code="v">19</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Members of the tyrosine kinase family are frequently implicated in experimental as well as in human cancer. The best studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying molecular mechanisms for aberrant receptor signaling in experimental systems and present the status of current therapies directed against the receptor. A detailed analysis of EGF receptor signal transduction via expression of receptor, ligands, phosphatases and presence of other members of the receptor family will provide new information for the design of therapeutic modalities targeting this receptor system</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumorwachstum</subfield><subfield code="0">(DE-588)4186432-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Epidermaler Wachstumsfaktor</subfield><subfield code="0">(DE-588)4271160-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Epidermaler Wachstumsfaktor-Rezeptor</subfield><subfield code="0">(DE-588)4271161-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1996</subfield><subfield code="z">Berlin</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Epidermaler Wachstumsfaktor-Rezeptor</subfield><subfield code="0">(DE-588)4271161-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Epidermaler Wachstumsfaktor</subfield><subfield code="0">(DE-588)4271160-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Tumorwachstum</subfield><subfield code="0">(DE-588)4186432-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lichtner, R. B.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harkins, R. N.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783662033937</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540617204</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783662033920</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-662-03391-3</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526647</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-662-03391-3</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift 1996 Berlin gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift 1996 Berlin |
| id | DE-604.BV046146462 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:30Z |
| institution | BVB |
| isbn | 9783662033913 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526647 |
| oclc_num | 1119089123 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XVI, 258 p. 67 illus) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| series2 | Ernst Schering Foundation Symposium Proceedings |
| spelling | EGF Receptor in Tumor Growth and Progression edited by R. B. Lichtner, R. N. Harkins Berlin, Heidelberg Springer Berlin Heidelberg 1997 1 Online-Ressource (XVI, 258 p. 67 illus) txt rdacontent c rdamedia cr rdacarrier Ernst Schering Foundation Symposium Proceedings 19 Members of the tyrosine kinase family are frequently implicated in experimental as well as in human cancer. The best studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying molecular mechanisms for aberrant receptor signaling in experimental systems and present the status of current therapies directed against the receptor. A detailed analysis of EGF receptor signal transduction via expression of receptor, ligands, phosphatases and presence of other members of the receptor family will provide new information for the design of therapeutic modalities targeting this receptor system Oncology Pharmacology/Toxicology Pharmacy Oncology Toxicology Tumorwachstum (DE-588)4186432-3 gnd rswk-swf Epidermaler Wachstumsfaktor (DE-588)4271160-5 gnd rswk-swf Epidermaler Wachstumsfaktor-Rezeptor (DE-588)4271161-7 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift 1996 Berlin gnd-content Krebs Medizin (DE-588)4073781-0 s Epidermaler Wachstumsfaktor-Rezeptor (DE-588)4271161-7 s DE-604 Epidermaler Wachstumsfaktor (DE-588)4271160-5 s Tumorwachstum (DE-588)4186432-3 s Lichtner, R. B. edt Harkins, R. N. edt Erscheint auch als Druck-Ausgabe 9783662033937 Erscheint auch als Druck-Ausgabe 9783540617204 Erscheint auch als Druck-Ausgabe 9783662033920 https://doi.org/10.1007/978-3-662-03391-3 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | EGF Receptor in Tumor Growth and Progression Oncology Pharmacology/Toxicology Pharmacy Oncology Toxicology Tumorwachstum (DE-588)4186432-3 gnd Epidermaler Wachstumsfaktor (DE-588)4271160-5 gnd Epidermaler Wachstumsfaktor-Rezeptor (DE-588)4271161-7 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4186432-3 (DE-588)4271160-5 (DE-588)4271161-7 (DE-588)4073781-0 (DE-588)4143413-4 (DE-588)1071861417 |
| title | EGF Receptor in Tumor Growth and Progression |
| title_auth | EGF Receptor in Tumor Growth and Progression |
| title_exact_search | EGF Receptor in Tumor Growth and Progression |
| title_full | EGF Receptor in Tumor Growth and Progression edited by R. B. Lichtner, R. N. Harkins |
| title_fullStr | EGF Receptor in Tumor Growth and Progression edited by R. B. Lichtner, R. N. Harkins |
| title_full_unstemmed | EGF Receptor in Tumor Growth and Progression edited by R. B. Lichtner, R. N. Harkins |
| title_short | EGF Receptor in Tumor Growth and Progression |
| title_sort | egf receptor in tumor growth and progression |
| topic | Oncology Pharmacology/Toxicology Pharmacy Oncology Toxicology Tumorwachstum (DE-588)4186432-3 gnd Epidermaler Wachstumsfaktor (DE-588)4271160-5 gnd Epidermaler Wachstumsfaktor-Rezeptor (DE-588)4271161-7 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Oncology Pharmacology/Toxicology Pharmacy Oncology Toxicology Tumorwachstum Epidermaler Wachstumsfaktor Epidermaler Wachstumsfaktor-Rezeptor Krebs Medizin Aufsatzsammlung Konferenzschrift 1996 Berlin |
| url | https://doi.org/10.1007/978-3-662-03391-3 |
| work_keys_str_mv | AT lichtnerrb egfreceptorintumorgrowthandprogression AT harkinsrn egfreceptorintumorgrowthandprogression |